MNPR SG&A Expense Growth
Monopar Therapeutics Inc · SG&A Expense Growth
MNPR SG&A Expense Growth
Latest reported215386.72%period ending
MNPR FY SG&A Growth (YoY) (0.00% → 215386.72%)
Latest values, visible window
High-resolution chart · PNG
MNPR sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 215,386.725% | |
| -2.3307% | |
| 9.7025% | |
| 11.8159% | |
| 7.7901% | |
| 3.7547% | |
| 44.6709% | |
| 39.6226% | |
| 27.7845% | |
| 55.4272% | |
| 0% |